Skip to main content
Peptides TT home

Glossary term

Amino Acid Sequence

An amino acid sequence is the ordered list of amino acid residues in a peptide, written from the N-terminus to the C-terminus, which defines its primary structure and molecular formula.

Also known as: Primary structure, Peptide sequence

The amino acid sequence of a peptide is the order in which its residues are joined by peptide bonds. By convention it is always written from the N-terminus (the free amine end) on the left to the C-terminus (the carboxyl end) on the right. The sequence is the single most important descriptor of a peptide: it fixes the molecular formula, the molecular weight and the charge at a given pH.

Reading the notation

Two coding systems are used side by side:

  • Three-letter codes, separated by hyphens, for example Tyr-Gly-Gly-Phe-Leu for Leu-Enkephalin.
  • One-letter codes, written as a continuous string, so the same peptide becomes YGGFL.

The cell-adhesion motif GRGDS is named directly after its one-letter sequence: Gly-Arg-Gly-Asp-Ser.

Modifications and special notation

Many research peptides carry modifications that must be shown in the sequence because they change the formula:

  • C-terminal amide, written -NH₂. Substance P, RPKPQQFFGLM-NH₂, is a familiar example.
  • N-terminal acetylation, written Ac- at the start.
  • Pyroglutamic acid, written pGlu or pE, where an N-terminal glutamine or glutamate has cyclised.
  • D-amino acids, shown with a D- prefix or, in one-letter code, as a lowercase letter.
  • Cyclic peptides, written with cyclo( ) around the ring, as in cyclo(RGDfK), where the lowercase f denotes D-phenylalanine.

Omitting a modification can shift the calculated mass by enough to make a correct product look wrong, or the reverse.

Why it matters in the lab

Matching the sequence exactly, including every modification, is the first step in confirming you have the right material. The sequence on a product listing should agree with the vial label, the certificate of analysis and the method you are following. Because the CAS Number belongs to one specific structure, a modified variant may carry a different number.

The sequence is also the basis for analytical checks. The expected mass calculated from it is compared with the observed result from mass spectrometry, and a residue-level discrepancy usually shows up as a clear mass difference.

Research peptides where Amino Acid Sequence matters

  • Sealed glass vial of lyophilized Tirzepatide research peptide, 30 mg, on a navy background

    CAS 2023788-19-2

    In stock

    Tirzepatide

    Dual GIP/GLP-1 receptor agonist peptide studied in metabolic research, supplied as a 30 mg lyophilized vial for in-vitro and analytical work.

    Purity
    Per batch COA
    Vial
    30 mg

    TT$2,000.00indicative

  • Sealed glass vial of lyophilized Retatrutide research peptide, 20 mg, on a navy background

    CAS 2381089-83-2

    In stock

    Retatrutide

    Investigational GIP, GLP-1 and glucagon triple receptor agonist peptide, supplied as a 20 mg lyophilized vial for in-vitro metabolic research.

    Purity
    Per batch COA
    Vial
    20 mg

    TT$2,200.00indicative

  • Sealed glass vial of lyophilized Tesamorelin research peptide, 10 mg, on a navy background

    CAS 218949-48-5

    In stock

    Tesamorelin

    Synthetic GHRH analogue: the 44-residue human GHRH sequence with an N-terminal trans-3-hexenoyl group, supplied as a 10 mg lyophilized vial.

    Purity
    Per batch COA
    Vial
    10 mg

    TT$1,200.00indicative